The Wall Street Journal reports black-market producers are pitching Americans substances for tanning, tissue repair and weight loss.
Recap by typeshit. Full story at The Wall Street Journal on MSN.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
17:54
Dr. Stirrett weighs the two drugs against each other for people over 50 trying to lose weight.
The FDA says retatrutide falls one alpha amino acid short. A biologic label would mean 12 years of exclusivity instead of 5, a later Medicare price clock and no compounding.
Loading…